USD 1.45
(-1.36%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -15.55 Million USD | -564.63% |
2022 | -3.19 Million USD | -1233.62% |
2021 | 206.45 Thousand USD | 146.51% |
2020 | -597.72 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q2 | -708.33 Thousand USD | 0.0% |
2023 Q4 | -10.45 Million USD | 0.0% |
2023 Q1 | -708.33 Thousand USD | 26.13% |
2022 Q2 | -638.06 Thousand USD | 0.0% |
2022 Q1 | -638.06 Thousand USD | 0.0% |
2022 Q3 | -958.88 Thousand USD | -50.28% |
2022 FY | - USD | -1233.62% |
2022 Q4 | -958.88 Thousand USD | 0.0% |
2021 FY | - USD | 146.51% |
2020 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 189.11 Million USD | 108.225% |
Addus HomeCare Corporation | 106.55 Million USD | 114.597% |
AirSculpt Technologies, Inc. | 28.31 Million USD | 154.94% |
Amedisys, Inc. | 216.91 Million USD | 107.171% |
American Oncology Network, Inc. | -39.35 Million USD | 60.472% |
Astrana Health, Inc. | 123.68 Million USD | 112.576% |
Aveanna Healthcare Holdings Inc. | 44.34 Million USD | 135.074% |
IMAC Holdings, Inc. | -5.94 Million USD | -161.564% |
biote Corp. | 9.23 Million USD | 268.45% |
Cryo-Cell International, Inc. | -10.41 Million USD | -49.316% |
Cross Country Healthcare, Inc. | 129.33 Million USD | 112.027% |
COMPASS Pathways plc | -123.8 Million USD | 87.436% |
DocGo Inc. | 32.72 Million USD | 147.531% |
The Ensign Group, Inc. | 353.23 Million USD | 104.403% |
Healthcare Services Group, Inc. | 75.21 Million USD | 120.681% |
InnovAge Holding Corp. | 1.15 Million USD | 1447.891% |
Assure Holdings Corp. | -19.82 Million USD | 21.536% |
The Joint Corp. | 9.14 Million USD | 270.15% |
LifeStance Health Group, Inc. | -104.92 Million USD | 85.176% |
ModivCare Inc. | -26.75 Million USD | 41.852% |
NewGenIvf Group Limited | 384.3 Thousand USD | 4147.48% |
Novo Integrated Sciences, Inc. | -5.84 Million USD | -165.937% |
Option Care Health, Inc. | 376.79 Million USD | 104.128% |
P3 Health Partners Inc. | -81.07 Million USD | 80.814% |
P3 Health Partners Inc. | -81.07 Million USD | 80.814% |
The Pennant Group, Inc. | 30.36 Million USD | 151.219% |
Surgery Partners, Inc. | 446.1 Million USD | 103.487% |
Syra Health Corp. Class A Common Stock | -2.83 Million USD | -448.494% |
Talkspace, Inc. | -22.01 Million USD | 29.339% |
Talkspace, Inc. | -22.01 Million USD | 29.339% |
The Oncology Institute, Inc. | -70.45 Million USD | 77.922% |
The Oncology Institute, Inc. | -70.45 Million USD | 77.922% |